Fisher & Paykel Healthcare Corporation has provided earnings guidance for the first half of the 2024 financial year.
The company expects operating revenue for the first half to be around $790 million, with net profit after tax ranging from approximately $95 million to $105 million.
This represents a 14% growth in revenue compared to the previous year.
The company's full-year revenue guidance of approximately $1.70 billion remains unchanged.
Fisher & Paykel Healthcare has also achieved significant milestones in the past year, including acquiring land in New Zealand, opening a new building in Mexico, and setting up a new manufacturing facility in China.
The company is confident in its long-term growth opportunities in respiratory therapies, surgical applications, and treatments for obstructive sleep apnea.
The Annual Shareholders' Meeting will be held today and will be broadcast online.
See more
